$DOUG
Douglas Elliman Inc. Stock $doug

$doug Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000187889723000018 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$275.9M	$214.0M	$308.9M
YoY Change	-24.27%	-30.73%	13.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$53.42M	$234.5M	$52.14M
YoY Change	-2.89%	349.86%	34.85%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.993M	$2.039M	$2.079M
YoY Change	0.35%	-1.92%	-2.07%
% of Gross Profit
Operating Expenses	$53.42M	$236.6M	$52.14M
YoY Change	-2.89%	353.77%	34.85%
Operating Profit	-$8.297M	-$23.81M	$7.879M
YoY Change	-156.72%	-402.17%	-44.62%
Interest Expense	$1.370M	$578.0K	$1.323M
YoY Change	20.49%	-56.31%	-2505.45%
% of Operating Profit			16.79%
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$6.471M	-$23.23M	$9.202M
YoY Change	-141.05%	-352.45%	-35.41%
Income Tax	-$1.293M	-$5.390M	$2.917M
% Of Pretax Income			31.7%
Net Earnings	-$5.219M	-$17.62M	$6.510M
YoY Change	-150.94%	-370.72%	-53.38%
Net Earnings / Revenue	-1.89%	-8.24%	2.11%
Basic Earnings Per Share	-$0.06	-$0.23	$0.08
Diluted Earnings Per Share	-$0.06	-$0.23	$0.08
COMMON SHARES
Basic Shares Outstanding	84.42M shares	84.42M shares	77.67M shares
Diluted Shares Outstanding	82.20M shares	78.28M shares	77.72M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$130.4M	$123.7M	$203.7M
YoY Change	-35.48%	-39.28%
Cash & Equivalents	$130.4M	$123.7M	$203.7M
Short-Term Investments
Other Short-Term Assets	$18.85M	$23.02M	$22.73M
YoY Change	16.18%	1.27%
Inventory
Prepaid Expenses
Receivables	$21.00M	$24.23M	$27.40M
Other Receivables	$24.25M	$27.15M	$14.60M
Total Short-Term Assets	$200.9M	$198.1M	$276.3M
YoY Change	-26.16%	-28.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.60M	$155.6M	$38.39M
YoY Change	2.54%	305.44%
Goodwill	$32.23M	$32.23M	$32.57M
YoY Change	0.0%	-1.05%
Intangibles
YoY Change
Long-Term Investments	$1.975M	$14.72M	$2.508M
YoY Change	-14.54%	487.08%
Other Assets	$6.757M	$6.633M	$5.510M
YoY Change	20.7%	20.38%
Total Long-Term Assets	$317.3M	$318.7M	$312.0M
YoY Change	-1.69%	2.17%
TOTAL ASSETS
Total Short-Term Assets	$200.9M	$198.1M	$276.3M
Total Long-Term Assets	$317.3M	$318.7M	$312.0M
Total Assets	$518.1M	$516.8M	$588.2M
YoY Change	-12.88%	-12.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.876M	$6.174M	$6.301M
YoY Change	-24.46%	-2.02%
Accrued Expenses	$28.73M	$26.18M	$30.58M
YoY Change	-20.02%	-14.4%
Deferred Revenue	$9.154M	$7.711M	$16.77M
YoY Change	51.53%	-54.03%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$9.405M
YoY Change
Total Short-Term Liabilities	$93.21M	$88.33M	$124.3M
YoY Change	-15.15%	-28.95%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$169.0K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$56.00K	$168.2M	$188.0K
YoY Change	-70.21%	89350.53%
Total Long-Term Liabilities	$56.00K	$168.2M	$357.0K
YoY Change	-84.09%	47005.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$93.21M	$88.33M	$124.3M
Total Long-Term Liabilities	$56.00K	$168.2M	$357.0K
Total Liabilities	$268.7M	$266.9M	$301.1M
YoY Change	-10.07%	-11.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.84M	-$22.62M	$3.070M
YoY Change	-400.94%	-836.94%
Common Stock	$886.0K	$844.0K	$812.0K
YoY Change	8.98%	3.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$248.1M	$249.9M	$285.0M
YoY Change
Total Liabilities & Shareholders Equity	$518.1M	$516.8M	$588.2M
YoY Change	-12.88%	-12.14%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$5.219M	-$17.62M	$6.510M
YoY Change	-150.94%	-370.72%	-53.38%
Depreciation, Depletion And Amortization	$1.993M	$2.039M	$2.079M
YoY Change	0.35%	-1.92%	-2.07%
Cash From Operating Activities	$8.435M	-$31.58M	-$6.780M
YoY Change	-12.29%	365.71%	-148.45%
INVESTING ACTIVITIES
Capital Expenditures	$987.0K	$3.627M	$849.0K
YoY Change	-128.06%	327.21%	42.21%
Acquisitions
YoY Change
Other Investing Activities	$258.0K	-$355.0K	-$966.0K
YoY Change	-121.32%	-63.25%
Cash From Investing Activities	-$729.0K	-$3.982M	-$1.815M
YoY Change	-84.58%	119.39%	204.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$0.00	$3.129M
YoY Change		-100.0%
Cash From Financing Activities	-12.00K	-$4.221M	-$6.834M
YoY Change	-99.84%	-38.24%	32442.86%
NET CHANGE
Cash From Operating Activities	8.435M	-$31.58M	-$6.780M
Cash From Investing Activities	-729.0K	-$3.982M	-$1.815M
Cash From Financing Activities	-12.00K	-$4.221M	-$6.834M
Net Change In Cash	7.694M	-$39.78M	-$15.43M
YoY Change	-422.46%	157.81%	-215.36%
FREE CASH FLOW
Cash From Operating Activities	$8.435M	-$31.58M	-$6.780M
Capital Expenditures	$987.0K	$3.627M	$849.0K
Free Cash Flow	$7.448M	-$35.20M	-$7.629M
YoY Change	-43.3%	361.42%	-156.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001878897
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	DOUGLAS ELLIMAN INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity File Number EntityFileNumber	1-41054
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2176850
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4400 Biscayne Boulevard
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33137
CY2023Q1	dei	City Area Code CityAreaCode	305
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	579-8000
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	DOUG
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	84416022	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	123662000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163859000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24227000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22162000	usd
CY2023Q1	doug	Agent Receivables Net Current AgentReceivablesNetCurrent	19507000	usd
CY2022Q4	doug	Agent Receivables Net Current AgentReceivablesNetCurrent	12826000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7647000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7547000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5404000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4985000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	17613000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	13680000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	198060000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	225059000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42544000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41717000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	113105000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	117773000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	5345000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	6219000	usd
CY2023Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	12669000	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	12932000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	36004000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	38913000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	32230000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	32230000	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	73489000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	73666000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2055000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1629000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6633000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6483000	usd
CY2023Q1	us-gaap	Assets Assets	516789000	usd
CY2022Q4	us-gaap	Assets Assets	550402000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22808000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22328000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6174000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5456000	usd
CY2023Q1	doug	Commissions Payable Current CommissionsPayableCurrent	25783000	usd
CY2022Q4	doug	Commissions Payable Current CommissionsPayableCurrent	22117000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3371000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18228000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7711000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8222000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22480000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13607000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	88327000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	89958000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9077000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14467000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	115192000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120508000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	52837000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54706000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	137000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	306000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	265570000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	279945000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32295000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84416022	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84416022	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80881022	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80881022	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	844000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	809000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	271678000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	273111000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22624000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	249898000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	268920000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1321000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1537000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	251219000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	270457000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	516789000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	550402000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213982000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	308900000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21239000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19306000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32830000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2039000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2079000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	1210000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23808000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7879000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1105000	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	39000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-73000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	532000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-454000	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	752000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23230000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9202000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5390000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2917000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-17840000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	6285000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-216000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-225000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-17624000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6510000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	270457000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-17840000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	4221000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2823000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	251219000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	281873000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	6285000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	4062000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2652000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	375000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	287123000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-17840000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	6285000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2039000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2079000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2823000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2652000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5390000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-454000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	752000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-73000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	532000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5400000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4876000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1428000	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	558000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	10361000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-339000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	100000	usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1167000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13257000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1246000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5568000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5868000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14857000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-18070000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2933000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	770000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31575000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6780000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	100000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	60000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	25000	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	701000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	275000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	25000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39778000	usd
CY2023Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	55000	usd
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	200000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3627000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	849000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3982000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1815000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3129000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4221000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4062000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2022Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	375000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	18000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4221000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6834000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15429000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171382000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	228866000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131604000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213437000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">:</span>The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Significant estimates subject to material changes in the near term include impairment charges and valuation of intangible assets. Actual results could differ from those estimates.
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-17624000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6510000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	307000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	307000	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	275000	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	275000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17931000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17931000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6235000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6235000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78279772	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77666210	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	54416	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78279772	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77720626	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	123662000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163859000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5404000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4985000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2538000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2538000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131604000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171382000	usd
CY2023Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-352000	usd
CY2022Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	154000	usd
CY2023Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	-102000	usd
CY2022Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	598000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-454000	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	752000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	213982000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	308900000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1614000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8069000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	8325000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	8169000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	278000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	257000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1078000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	985000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	153000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	121000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	9528000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	9290000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	8524000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	9196000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	732000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6984000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0875
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0873
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	25989000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	29863000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	25096000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	22733000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	19912000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18129000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	46053000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	187775000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	49775000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	138000000	usd
CY2023Q1	doug	Lessee Operating Lease Lease Notyet Commenced Amount LesseeOperatingLeaseLeaseNotyetCommencedAmount	217000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P5Y
CY2023Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	2630000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	2957000	usd
CY2023Q1	us-gaap	Alternative Investment AlternativeInvestment	2715000	usd
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	3262000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8863000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8588000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	497000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Investments Investments	14705000	usd
CY2022Q4	us-gaap	Investments Investments	14807000	usd
CY2023Q1	us-gaap	Debt Securities Current DebtSecuritiesCurrent	1539000	usd
CY2022Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	1875000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	497000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	12669000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	12932000	usd
CY2023Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-352000	usd
CY2022Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	154000	usd
CY2023Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	-102000	usd
CY2022Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	598000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-454000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	752000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-102000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	598000	usd
CY2023Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	1030000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8863000	usd
CY2023Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	2055000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23230000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9202000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5390000	usd
CY2022Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2917000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5390000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2917000	usd
CY2023Q1	us-gaap	Revenues Revenues	213982000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23808000	usd
CY2023Q1	doug	Adjusted Earnings Before Interest Taxes Depreciation And Amortization Attributable To Parent AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToParent	-17645000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2039000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3627000	usd
CY2022Q1	us-gaap	Revenues Revenues	308900000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7879000	usd
CY2022Q1	doug	Adjusted Earnings Before Interest Taxes Depreciation And Amortization Attributable To Parent AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToParent	12727000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2079000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	849000	usd
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	27505000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	33533000	usd

Files In Submission

Name	View Source	Status
doug-20230331_cal.xml	Edgar Link	unprocessable
0001878897-23-000018-index-headers.html	Edgar Link	pending
0001878897-23-000018-index.html	Edgar Link	pending
0001878897-23-000018.txt	Edgar Link	pending
0001878897-23-000018-xbrl.zip	Edgar Link	pending
a2023q1ex311.htm	Edgar Link	pending
a2023q1ex312.htm	Edgar Link	pending
a2023q1ex321.htm	Edgar Link	pending
doug-20230331.htm	Edgar Link	pending
doug-20230331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
doug-20230331_def.xml	Edgar Link	unprocessable
doug-20230331_lab.xml	Edgar Link	unprocessable
doug-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
doug-20230331_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOUG
Douglas Elliman Inc. Stock $doug

2023 Q2 Form 10-Q Financial Statement

#000187889723000018 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOUG Douglas Elliman Inc. Stock $doug

2023 Q2 Form 10-Q Financial Statement

#000187889723000018 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOUG
Douglas Elliman Inc. Stock $doug